Patheon announced that it plans to sell its facility in Carolina, PR, while retaining two other sites in Caguas and Manati. The announcement came during the company’s 4Q07 financial statement. The quarter ended October 31. The Carolina site is a 230,000-square-foot facility with 200 employees, and specializes in the manufacture of oral cephalosporin solid dosage forms, including tablets, capsules and powders for suspension. The facility currently manufactures four products for six clien...